VenoStent
Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patients. The company's technology is made from a new class of shape-memory polymers us...
Valuation
$0
Share Price
N/A
Total Raised
$22.8M
Last Round
N/A